Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

Market Cap	6.21B +15.5%
Revenue (ttm)	786.51M -0.5%
Net Income	74.61M +19.4%
EPS	0.18 +19.3%
Shares Out	417.60M
PE Ratio	83.20
Forward PE	n/a
Dividend	0.10 (0.68%)
Ex-Dividend Date	Sep 9, 2025

Volume	1,501,656
Average Volume	3,874,703
Open	14.90
Previous Close	14.81
Day's Range	14.77 - 14.93
52-Week Range	11.42 - 22.69
Beta	-0.22
RSI	40.65
Earnings Date	Apr 24, 2026

About SHE:002907

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 1,384
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002907

Financial Performance

In 2024, SHE:002907's revenue was 774.82 million, an increase of 12.04% compared to the previous year's 691.54 million. Earnings were 76.73 million, an increase of 134.66%.